Literature DB >> 20015616

Distribution of EFHC1 or Myoclonin 1 in mouse neural structures.

Christine Léon1, Laurence de Nijs, Grazyna Chanas, Antonio V Delgado-Escueta, Thierry Grisar, Bernard Lakaye.   

Abstract

EFHC1, a gene mutated in juvenile myoclonic epilepsy, encodes EFHC1, a protein with three DM10 domains and one EF-hand motif. We recently demonstrated that this molecule is a microtubule-associated protein (MAP) implicated in neuronal migration. Because some controversies persist about the precise localization in the CNS, we studied the neuroanatomical distribution of EFHC1 in mature and developing mouse brain. In the adult, low mRNA expression was detected in several brain structures such as cortex, striatum, hippocampus and cerebellum. At E16, EFHC1 mRNA was shown to be expressed in cortex and not only in cells lining ventricles. Using a purified polyclonal antibody, EFHC1 staining was observed in all cortical layers, in piriform cortex, in hippocampus and in Purkinje cells of cerebellum. In the cortex, the majority of EFHC1 positive cells correspond to neurons, however some glial cells were also stained. In agreement with a previous study, we demonstrated strong EFHC1 expression in cilia of ependymal cells lining cerebral ventricles. Moreover, at E16, the protein was observed at the borders of brain ventricles, in choroid plexus, but also, although to a lesser extent, in piriform and neocortex. In these latter structures, the pattern of expression seems to correspond to the extensions of the radial glia fibers as demonstrated by BLBP immunostaining. Finally, we confirmed that EFHC1 was also expressed and co-localized with the mitotic spindle of neural stem cells. These results confirm that EFHC1 is a protein with a likely low expression level in mouse brain but detectable both in adult and embryonic brain supporting our previous data and hypothesis that EFHC1 could play an important role during brain development. As discussed, this opens the door to a new conceptual approach viewing some idiopathic generalized epilepsies as developmental diseases instead of classical channelopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015616     DOI: 10.1016/j.eplepsyres.2009.11.009

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

Review 1.  Genes and molecular pathways underpinning ciliopathies.

Authors:  Jeremy F Reiter; Michel R Leroux
Journal:  Nat Rev Mol Cell Biol       Date:  2017-07-12       Impact factor: 94.444

2.  Contrast gain control abnormalities in idiopathic generalized epilepsy.

Authors:  Jeffrey J Tsai; Anthony M Norcia; Justin M Ales; Alex R Wade
Journal:  Ann Neurol       Date:  2011-06-27       Impact factor: 10.422

3.  Mutations of EFHC1, linked to juvenile myoclonic epilepsy, disrupt radial and tangential migrations during brain development.

Authors:  Laurence de Nijs; Nathalie Wolkoff; Bernard Coumans; Antonio V Delgado-Escueta; Thierry Grisar; Bernard Lakaye
Journal:  Hum Mol Genet       Date:  2012-08-27       Impact factor: 6.150

4.  Epilepsy protein Efhc1/myoclonin1 is expressed in cells with motile cilia but not in neurons or mitotic apparatuses in brain.

Authors:  Toshimitsu Suzuki; Ikuyo Inoue; Kazuhiro Yamakawa
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

5.  Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestry.

Authors:  Ryan L Subaran; Juliette M Conte; William C L Stewart; David A Greenberg
Journal:  Epilepsia       Date:  2014-12-08       Impact factor: 5.864

6.  Juvenile myoclonic epilepsy: EFHC1 at the cross-roads?

Authors:  Subramaniam Ganesh
Journal:  Ann Neurosci       Date:  2010-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.